Farinati F, Floreani A, De Maria N, Fagiuoli S, Naccarato R, Chiaramonte M
Cattedra Malattie Apparato Digerente, Istituto di Medicina Interna, Università di Padova, Italy.
J Hepatol. 1994 Sep;21(3):315-6. doi: 10.1016/s0168-8278(05)80307-1.
Primary biliary cirrhosis is considered a low risk for the development of hepatocellular carcinoma. We evaluated the incidence of hepatocellular carcinoma in a cohort of 89 female primary biliary cirrhosis patients and, as a control group in 73 female patients with cirrhosis of a different etiology. The patients underwent ultrasound and alfa-fetoprotein determination every 6 months. Two patients developed hepatocellular carcinoma in the primary biliary cirrhosis and three in the control group, respectively. The Relative Risk for hepatocellular carcinoma in primary biliary cirrhosis patients was 0.7. However, when considering only stage IV, primary biliary cirrhosis patients with cirrhosis, the Relative Risk was actually 1.5 with respect to controls, with 1.4% cases of hepatocellular carcinoma per year. These data suggest that the risk of hepatocellular carcinoma is similar in female patients with primary biliary cirrhosis and in female patients with cirrhosis of a different etiology.
原发性胆汁性肝硬化被认为发生肝细胞癌的风险较低。我们评估了一组89例女性原发性胆汁性肝硬化患者中肝细胞癌的发病率,并将73例不同病因肝硬化的女性患者作为对照组。患者每6个月接受一次超声检查和甲胎蛋白测定。原发性胆汁性肝硬化组和对照组分别有2例和3例发生肝细胞癌。原发性胆汁性肝硬化患者发生肝细胞癌的相对风险为0.7。然而,仅考虑IV期原发性胆汁性肝硬化患者时,相对于对照组,其相对风险实际上为1.5,每年肝细胞癌发生率为1.4%。这些数据表明,女性原发性胆汁性肝硬化患者和不同病因肝硬化的女性患者发生肝细胞癌的风险相似。